novartis - dofaq.co
Morphosys says takeover by Novartis on course after report of drug safety concern
Reuters - 29 Apr 2024
Morphosys says takeover by Novartis on course after report of drug safety concern ...
Novartis: Innovating for the world, from India
Forbes India - 15 Apr 2024
Novartis: Innovating for the world, from India ...
Novartis pays PeptiDream $180M as radiopharma big bang continues
Fierce Biotech - 30 Apr 2024
Novartis pays PeptiDream $180M as radiopharma big bang continues ...
India becoming attractive for clinical trials, says pharma industry leaders
The Economic Times - 27 Apr 2024
India becoming attractive for clinical trials, says pharma industry leaders ...
New, serious safety risk related to MorphoSys' cancer drug complicates, potentially threatens, Novartis acquisition
STAT - 28 Apr 2024
New, serious safety risk related to MorphoSys' cancer drug complicates, potentially threatens, Novartis acquisition ...
Novartis raises guidance after beating Q1 expectations
Moneycontrol - 24 Apr 2024
Novartis raises guidance after beating Q1 expectations ...
Research and development
Novartis - 08 Feb 2024
Research and development ...
Safety Concerns with MorphoSys’ Blood Cancer Drug Could Mar $2.9B Novartis Buy: STAT
BioSpace - 29 Apr 2024
Safety Concerns with MorphoSys’ Blood Cancer Drug Could Mar $2.9B Novartis Buy: STAT ...
Novartis eyes sale of listed unit in India, says Global CEO Narasimhan
Business Standard - 22 Mar 2024
Novartis eyes sale of listed unit in India, says Global CEO Narasimhan ...
Alexion and Novartis/Genentech start UPC's first ever biosimilar disputes
IAM - 24 Apr 2024
Alexion and Novartis/Genentech start UPC's first ever biosimilar disputes ...
Novartis, Neurocrine-Takeda, Enhertu—Fierce Pharma Asia
FiercePharma - 26 Apr 2024
Novartis, Neurocrine-Takeda, Enhertu—Fierce Pharma Asia ...
Novartis set to launch chronic myeloid leukemia drug in India | Mint
Mint - 14 Mar 2024
Novartis set to launch chronic myeloid leukemia drug in India | Mint ...
USFDA gives nod to Novartis’ therapy for rare cancer among children
The Financial Express - 25 Apr 2024
USFDA gives nod to Novartis’ therapy for rare cancer among children ...
PeptiDream Announces Expansion of Peptide Discovery Collaboration with Novartis
Business Wire - 30 Apr 2024
PeptiDream Announces Expansion of Peptide Discovery Collaboration with Novartis ...
Deciphex partners with Novartis for AI drug research
SiliconRepublic.com - 29 Apr 2024
Deciphex partners with Novartis for AI drug research ...
Novartis in Society Integrated Report
Novartis - 31 Jan 2024
Novartis in Society Integrated Report ...
Novartis India share price surges nearly 11% to hit a 52-week high as Novartis AG announces sale plans for the co | Mint
Mint - 19 Feb 2024
Novartis India share price surges nearly 11% to hit a 52-week high as Novartis AG announces sale plans for the co | Mint ...
Novartis will start doing more fundamental research work in India: Vas Narasimhan
Forbes India - 17 Apr 2024
Novartis will start doing more fundamental research work in India: Vas Narasimhan ...
Novartis puts its India-listed entity for up for sale
The Economic Times - 16 Feb 2024
Novartis puts its India-listed entity for up for sale ...